Truist Securities confirmed its positive stance on Iovance Biotherapeutics (NASDAQ:IOVA) shares, maintaining a Buy rating and a price target of $25.00. With the stock currently trading at $6.07, this ...
As rights-backed securitization deals grow more prevalent in the music industry, Influence Media Partners has obtained $360 ...
Fintel reports that on January 29, 2025, Truist Securities initiated coverage of Larimar Therapeutics (NasdaqGM:LRMR) with a ...
Influence Media Partners has confirmed that it has secured approximately $360 million in debt financing through an inaugural ...
Geneos Wealth Management Inc. boosted its position in shares of Truist Financial Co. (NYSE:TFC – Free Report) by 3.2% in the ...
Truist also published new coverage on Cloudflare today, maintaining a buy rating on the stock and raising its one-year price target from $120 per share to $140 per share. Notably, today's gains pushed ...
We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we are going to take a look at ...
Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...
Bank of America ( BAC -0.77%) stock had quite a good 2024, cruising more than 30% higher in price to notch a convincing beat ...
Investors with a lot of money to spend have taken a bearish stance on Tesla TSLA. And retail traders should know. We noticed ...